Appointment of Master Distributor in the United States
Filed with ASX · · 5 pages · English
Singular Health Group Ltd on 6ix
Earlier from Singular Health
- Capital Raise & Corporate Mandate
- Resignation of Managing Director and Strategic Review
- Operational Update, R&D Funding Facility & Strategic Review
- Singular Attains ISO13485 Certification
- Sales Partner Appointed and First Enterprise Licence Order
Later from Singular Health
- Strategic Investment from Master Distributor in USA
- Preliminary Final Report
- Appointment of Managing Director and Chief Executive Officer
- Singular Receives R&D Tax Incentive Refund
- Singular Receives Commitment for $850,000 from CG1 Ventures
Follow Singular Health into a list and get an email when it puts out news.
Follow Singular Health